StockData
DexCom Inc logo

DexCom Inc (DXCM) stock

DXCMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 22/3031% below fair value
$82.04+0.43 (+0.53%)

Close on Nov 17, 2026Market cap $30.60BP/E 32.3Yield –

DexCom cash

Cash and short-term investments held at the end of each period.

DexCom's cash was $961.40M at Sep 30, 2026. For fiscal 2025 it was $917.70M, down 60.7% from the year before. Over ten years it grew 23.1% a year on average. The highest annual figure on record is $2.73B in fiscal 2023.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$917.70M-60.7%
FY2024Dec 31, 2024$2.34B-14.3%
FY2023Dec 31, 2023$2.73B+11.1%
FY2022Dec 31, 2022$2.45B+1.6%
FY2021Dec 31, 2021$2.41B+195.0%
FY2020Dec 31, 2020$818.20M+83.3%
FY2019Dec 31, 2019$446.40M-63.7%
FY2018Dec 31, 2018$1.23B+124.2%
FY2017Dec 31, 2017$548.60M+343.5%
FY2016Dec 31, 2016$123.70M+7.4%
FY2015Dec 31, 2015$115.20M+37.8%
FY2014Dec 31, 2014$83.60M+53.1%
FY2013Dec 31, 2013$54.60M+12.1%
FY2012Dec 31, 2012$48.70M-40.5%
FY2011Dec 31, 2011$81.90M+73.8%
FY2010Dec 31, 2010$47.12M+1209.0%
FY2009Dec 31, 2009$3.60M-71.7%
FY2008Dec 31, 2008$12.70M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$961.40M-47.6%
Q2 FY2026Jun 30, 2026$1.11B-4.7%
Q1 FY2026Mar 31, 2026$1.12B-54.6%
Q4 FY2025Dec 31, 2025$917.70M-60.7%
Q3 FY2025Sep 30, 2025$1.84B-19.2%
Q2 FY2025Jun 30, 2025$1.16B-61.0%
Q1 FY2025Mar 31, 2025$2.46B-6.0%
Q4 FY2024Dec 31, 2024$2.34B-14.3%
Q3 FY2024Sep 30, 2024$2.27B-30.0%
Q2 FY2024Jun 30, 2024$2.97B-18.3%
Q1 FY2024Mar 31, 2024$2.62B+2.3%
Q4 FY2023Dec 31, 2023$2.73B+11.1%
Q3 FY2023Sep 30, 2023$3.24B+37.0%
Q2 FY2023Jun 30, 2023$3.63B+31.9%
Q1 FY2023Mar 31, 2023$2.56B-1.0%
Q4 FY2022Dec 31, 2022$2.45B+1.6%
Q3 FY2022Sep 30, 2022$2.37B-6.3%
Q2 FY2022Jun 30, 2022$2.75B+137.7%
Q1 FY2022Mar 31, 2022$2.59B+252.8%
Q4 FY2021Dec 31, 2021$2.41B+195.0%
Q3 FY2021Sep 30, 2021$2.53B+275.4%
Q2 FY2021Jun 30, 2021$1.16B+118.6%
Q1 FY2021Mar 31, 2021$733.80M+25.5%
Q4 FY2020Dec 31, 2020$818.20M+83.3%
Q3 FY2020Sep 30, 2020$673.50M+70.2%
Q2 FY2020Jun 30, 2020$530.00M-25.3%
Q1 FY2020Mar 31, 2020$584.60M-54.5%
Q4 FY2019Dec 31, 2019$446.40M-63.7%
Q3 FY2019Sep 30, 2019$395.60M-40.8%
Q2 FY2019Jun 30, 2019$709.20M+17.0%
Q1 FY2019Mar 31, 2019$1.29B+140.7%
Q4 FY2018Dec 31, 2018$1.23B+124.2%
Q3 FY2018Sep 30, 2018$668.70M+27.2%
Q2 FY2018Jun 30, 2018$606.10M+22.0%
Q1 FY2018Mar 31, 2018$533.90M+194.8%
Q4 FY2017Dec 31, 2017$548.60M+343.5%
Q3 FY2017Sep 30, 2017$525.80M–
Q2 FY2017Jun 30, 2017$496.60M–
Q1 FY2017Mar 31, 2017$181.10M–
Q4 FY2016Dec 31, 2016$123.70M–

More DexCom figures

See a number that looks wrong?